AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $877,000 | -36.2% | 31,000 | -50.0% | 0.00% | -50.0% |
| Q2 2022 | $1,375,000 | -47.5% | 62,000 | -17.1% | 0.00% | -33.3% |
| Q3 2020 | $2,618,000 | -33.2% | 74,800 | -38.2% | 0.00% | 0.0% |
| Q3 2019 | $3,920,000 | +56.2% | 121,000 | +140.6% | 0.00% | +50.0% |
| Q2 2019 | $2,509,000 | -55.6% | 50,300 | -27.2% | 0.00% | -33.3% |
| Q2 2018 | $5,651,000 | 0.0% | 69,100 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $5,651,000 | +479.6% | 69,100 | +334.6% | 0.01% | +100.0% |
| Q3 2014 | $975,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |